Conformer Distribution in (cis-1,4-DACH)bis(guanosine-5′-phosphate)platinum(II) Adducts: A Reliable Model for DNA Adducts of Antitumoral Cisplatin-Reference-Cited by-同舟云学术

Conformer Distribution in (cis-1,4-DACH)bis(guanosine-5′-phosphate)platinum(II) Adducts: A Reliable Model for DNA Adducts of Antitumoral Cisplatin

Published:2008-02-20 Issue:7 Volume:47 Page:2820-2830
ISSN:0020-1669
Container-title:Inorganic Chemistry
language:en
Short-container-title:Inorg. Chem.

Author:

Ranaldo Rosa¹,Margiotta Nicola¹,Intini Francesco P.¹,Pacifico Concetta¹,Natile Giovanni¹

Affiliation:

1. Dipartimento Farmaco-Chimico, Università degli Studi di Bari, Via E. Orabona 4, 70125 Bari, Italy

Publisher

American Chemical Society (ACS)

Subject

Inorganic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ic702202x

Reference81 articles.

1. Cisplatin

2. Krakoff, I. H.InPlatinum and Other Metal Coordination Compounds in Cancer Chemotherapy: Clinical Applications of Platinum Complexes;Nicolini, M., Ed.Martinus Nijhoff Publishers:Boston, 1988; p351.

3. Current Status of Platinum-Based Antitumor Drugs

4. Preclinical studies identifying carboplatin as a viable cisplatin alternative

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interactions with DNA Models of the Oxaliplatin Analog (cis-1,3-DACH)PtCl2;International Journal of Molecular Sciences;2024-07-05

2. Interaction of Copper Trafficking Proteins with the Platinum Anticancer Drug Kiteplatin;ChemMedChem;2021-11-15

3. Pt(iv) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity;Dalton Transactions;2021

4. Current Development of Metal Complexes with Diamine Ligands as Potential Anticancer Agents;Current Medicinal Chemistry;2020-02-19

5. A minimal structural variation can overcome tumour resistance of oxaliplatin: the case of 4,5-dehydrogenation of the cyclohexane ring;RSC Advances;2019